Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 2, 2022

View Archived Issues

New murine model of AIH developed using a human liver protein

Science & Technology Development Fund Authority presents new antiviral nucleosides

New DDR1 and/or DDR2 inhibitors identified at Galapagos

PI3K-delta inhibitors patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Sichuan Haisco Pharmaceutical discovers polymerase basic protein 2 inhibitors

Beijing Findcure Biosciences divulges new tyrosine-protein kinase receptor UFO inhibitors

SLAMF3 and SLAMF4 targeting for treating hematopoietic cancers

HMGB1 restricts EPO signaling, contributing to anemia of inflammation

CCR4 mediates postoperative pain through skin dendritic cells

Sarepta and GenEdit report progress under collaboration for neuromuscular diseases

Catalog of protein isoforms in blood cells can predict organ rejection

Skye reports data on SBI-100 ophthalmic nanoemulsion in preclinical glaucoma model

Neuronal PFKFB3 upregulation involved in ceroid lipofuscinosis

Discovery of novel ATX inhibitor with promising antifibrosis efficacy in rodents

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...